STAT+: AbbVie skin disorder drug succeeds in late-stage trial, but results miss market expectations
1newsrooms
1articles
under an hourrunning
Oct 22first seen
Ask Scout
Scout answers questions about this story using only the coverage below.
Coverage over time
Articles
| Oct 22, 11:22 AM | statnews.com | STAT+: AbbVie skin disorder drug succeeds in late-stage trial, but results miss market expectations |